Back to Results
First PageMeta Content
Pharmacology / Clinical research / ATryn / Anticoagulants / Genetic engineering / Goats / Validation / Food and Drug Administration / Heparin / Pharmaceutical sciences / Biology / Pharmaceutical industry


Approval of Biologics License Application from GTC Biotherapeutics, Inc. for Antithrombin
Add to Reading List

Open Document

File Size: 310,71 KB

Share Result on Facebook

City

Framingham / /

Company

GTC Biotherapeutics Inc. / /

Country

Netherlands / /

Event

FDA Phase / /

Facility

Inc. facility / Laboratory of Hemostasis/DH/OBRR Subject / GTC facility / /

IndustryTerm

final drug product / final drug products / process equipment / manufacturing runs / manufacturing steps / rAT processing / manufacturing facilities / physico-chemical and structural properties / proposed commercial manufacturing site / manufacturing / manufacturing milk pools / rAT final drug product / manufacturing process / /

MedicalCondition

hereditary deficiency / congenital AT deficiency / diseases / /

MedicalTreatment

intravenous infusion / /

Organization

Review Committee / Department of Health and Human Services / MEMORANDUM Department of Health / Food and Drug Administration Center for Biologics Evaluation and Research To / Laboratory of Hemostasis/DH/OBRR Subject / /

Person

Timothy Lee / Iftekhar Mahmood / Chiang Syin / Philip Snoy / Paul Hsieh (Biostatistics) / Roman Drews / Joseph Manik / Maryann Gallagher / Faith Barash (Epidemiology) / Evi Struble / Nisha Jain / /

Position

Acting Chief / Chair / /

Product

sodium chloride / glycine / ATryn® / /

ProvinceOrState

Massachusetts / /

SocialTag